Potential Significance of Targeting Ferroptosis for Intervention of Diabetic Cardiomyopathy

Qian Lei1,2, Burton B Yang3, Juanjuan Lyu4,5

  • 1Anesthesia and Operation Center, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Journal of Diabetes
|June 19, 2025
PubMed
Abstract

Insights

Diabetic cardiomyopathy (DCM) is a serious diabetes complication. Ferroptosis, a cell death pathway driven by oxidative stress, offers a promising target for new DCM treatments.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disorders
  • Cellular Biology

Background:

  • Diabetic cardiomyopathy (DCM) is a major cause of mortality in diabetes patients.
  • Current therapeutic and preventative strategies for DCM are limited.
  • Understanding DCM pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To summarize the pathogenesis and clinical treatment of DCM.
  • To review the role of ferroptosis in DCM.
  • To explore the potential of ferroptosis inhibitors for DCM intervention.

Main Methods:

  • Literature review of recent studies on DCM.
  • Analysis of the impact of ferroptosis on DCM.
  • Evaluation of ferroptosis inhibitors as therapeutic agents.

Main Results:

  • Oxidative stress and inflammation contribute to DCM development.
  • Increased reactive oxygen species (ROS) in cardiomyocytes induce cell death via ferroptosis.
  • Ferroptosis inhibitors show significant therapeutic potential for DCM.

Conclusions:

  • Iron homeostasis, oxidative stress, and ferroptosis are key factors in DCM.
  • Ferroptosis plays a critical role in the prevention and treatment of DCM.
  • Targeting ferroptosis presents a promising avenue for managing diabetic cardiomyopathy.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
65